Recruiting Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement NCT05727176 Conditions Adenocarcinoma, Advanced Cholangiocarcinoma, Carcinoma, +6 more Locations University of California San Diego UCSD - Moores Cancer Center — La Jolla, California, United States Tampa General Hospital Cancer Institute — Tampa, Florida, United States Henry Ford Health System — Detroit, Michigan, United States Gabrail Cancer Center Research — Canton, Ohio, United States View all 65 locations View more locations Show fewer locations Loading locations... View Trial Details
